Valiant Laboratories Share Price

NSE
VALIANTLAB •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Valiant Laboratories
Valiant Laboratories Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Valiant Laboratories Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
New 52W Low today
-32.9
Dividend yield 1yr %
0

Valiant Laboratories Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Valiant Laboratories Quarterly Revenue

Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
35.23 Cr
21.48 Cr
18.88 Cr
30.59 Cr
40.52 Cr

Valiant Laboratories Yearly Revenue

Mar 2024Mar 2023
191.74 Cr
338.77 Cr

Valiant Laboratories Quarterly Net Profit/Loss

Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
2.35 Cr
-4.74 Cr
-0.51 Cr
-1.24 Cr
-3.5 Cr

Valiant Laboratories Yearly Net Profit/Loss

Mar 2024Mar 2023
0.32 Cr
29 Cr
Valiant Laboratories Result Highlights
  • Valiant Laboratories Ltd reported a 48.2% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a decline of 13.0%.

  • Its expenses for the quarter were up by 22.4% QoQ and down 25.6% YoY.

  • The net profit decreased 149.6% QoQ and decreased 167.1% YoY.

  • The earnings per share (EPS) of Valiant Laboratories Ltd stood at 0.5 during Q3FY25.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Valiant Laboratories shareholding Pattern

Promoter
74.9%
Public
25.1%
Promoter
74.9%
Public
25.1%
Promoter
74.9%
Foreign Institutions
1.9%
Public
23.2%
Promoter
74.9%
Foreign Institutions
3.5%
Public
21.6%
Promoter
74.9%
Foreign Institutions
7.1%
Domestic Institutions
0.4%
Public
17.5%
Promoter
74.9%
Foreign Institutions
8.6%
Domestic Institutions
3.9%
Public
12.5%

Valiant Laboratories Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
16
5Day EMA
79.20
10Day EMA
80.90
12Day EMA
81.40
20Day EMA
83.60
26Day EMA
85.40
50Day EMA
91.50
100Day EMA
100.50
200Day EMA
115.40
5Day SMA
79.80
10Day SMA
81.60
20Day SMA
82.40
30Day SMA
86.20
50Day SMA
93.00
100Day SMA
103.50
150Day SMA
108.20
200Day SMA
114.60
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
58680 Rs
101097 Rs
Week Rs
254888 Rs
299353 Rs
Month Rs
120161 Rs
155239 Rs
Resistance & Support
77.67
Pivot
Resistance
First Resistance
80.15
Second Resistance
83.71
Third Resistance
86.19
Support
First Support
74.11
Second support
71.63
Third Support
68.07
Relative Strength Index
30.16
Money Flow Index
18.52
MACD
-3.93
MACD Signal
-3.97
Average True Range
4.38
Average Directional Index
29.49
Rate of Change (21)
-15.81
Rate of Change (125)
-35.47

Valiant Laboratories Company background

Founded in: 2021
Managing director: Santosh S. Vora
Valiant Laboratories Limited was originally formed as a Partnership Firm under the name and style of M/s. Bharat Chemicals through Deed of Partnership dated October 17, 1980. The said Partnership Firm, M/s. Bharat Chemicals thereafter converted into a Public Limited Company with the name Valiant Laboratories Limited through certificate of incorporation dated August 16, 2021 issued by the Central Registration Centre, Registrar of Companies.The Company is an Active Pharmaceutical Ingredient (API) / Bulk Drug manufacturing company having focus on manufacturing of Paracetamol. The Company gradually, commenced manufacturing of Paracetamol by late 1982. Paracetamol (Scientific name: Acetaminophen or parahydroxyacetanilide C8H9NO2), is one of the most commonly taken analgesic worldwide and is recommended as the firstline therapy in pain conditions by the World Health Organization (WHO). Paracetamol has several applications such as usage in treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold and fever. It manufacture Paracetamol in various grades such as IP/BP/EP/USP, as per the pharmacopeia requirements of customers.Paracetamol is available in a variety of forms including syrup form, regular tablets, effervescent tablets, injection, suppository, and other forms. Paracetamol is often found combined with other drugs in many over the counter (OTC) allergy medications, cold medications, sleep medications, pain relievers, and other products. Presently, the Company is engaged in manufacturing and dealing in Pharmaceuticals and specility chemicals. The manufacturing facility is located at Tarapur Industrial Area, Boisar in the State of Maharashtra, with an annual installed capacity of 9,000 MTPA. Within the Manufacturing Facility located at Tarapur Industrial Area, Palghar, Maharashtra, the Company has an inhouse RD infrastructure which is equipped with analytical laboratory and infrastructure for developmental activities in existing product. The Company is promoted by Shantilal Shivji Vora, Director and Dhanvallabh Ventures LLP (DVL). In July, 2022 the Company formed its wholly owned subsidiary, Valiant Advanced Sciences Private Limited (VASPL) to diversify the business activities.The Company has come out with a Public Issue of issuing upto 11,556,000 Equity Shares through fresh issue.
Read More

Valiant Laboratories FAQs

Valiant Laboratories share price is ₹76.58 in NSE and ₹76.79 in BSE as on 27/3/2025.

Valiant Laboratories share price in the past 1-year return was -47.2. The Valiant Laboratories share hit a 1-year low of Rs. 75.2 and a 1-year high of Rs. 171.9.

The market cap of Valiant Laboratories is Rs. 332.74 Cr. as of 27/3/2025.

The PE ratios of Valiant Laboratories is 0 as of 27/3/2025.

The PB ratios of Valiant Laboratories is 1.45 as of 27/3/2025

You can easily buy Valiant Laboratories shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Valiant Laboratories stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -